Tellier, Zera.
Intravenous immunoglobulins myth and reality / [electronic resource] : Zera Tellier. - London : Henry Stewart Talks, 2007. - 1 online resource (1 streaming video file (25 min.) : color, sound). - Autoimmunity : etiology, pathogenesis, clinical manifestation and diagnostic methodologies, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Autoimmunity : etiology, pathogenesis, clinical manifestation and diagnostic methodologies. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: The use of intravenous immunoglobulins (IVIg) as therapeutic proteins -- Use of IVIg to provide effective treatment for autoimmune thrombocytopenic purpura -- Use of IVIg in a large range of autoimmune or systemic inflammatory diseases -- Increase in worldwide IVIg demand -- Increased evidence showing the efficacy of IVIg -- Mechanisms for the action of IVIg in autoimmune diseases -- Need for classification of the recommendations for use -- Clinical indications for IVIg therapy.
Access restricted to subscribers.
Mode of access: World Wide Web.
1529 Henry Stewart Talks
Autoimmune Diseases.
Autoimmunity.
Immunoglobulins, Intravenous--therapeutic use.
Research.
Intravenous immunoglobulins myth and reality / [electronic resource] : Zera Tellier. - London : Henry Stewart Talks, 2007. - 1 online resource (1 streaming video file (25 min.) : color, sound). - Autoimmunity : etiology, pathogenesis, clinical manifestation and diagnostic methodologies, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Autoimmunity : etiology, pathogenesis, clinical manifestation and diagnostic methodologies. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: The use of intravenous immunoglobulins (IVIg) as therapeutic proteins -- Use of IVIg to provide effective treatment for autoimmune thrombocytopenic purpura -- Use of IVIg in a large range of autoimmune or systemic inflammatory diseases -- Increase in worldwide IVIg demand -- Increased evidence showing the efficacy of IVIg -- Mechanisms for the action of IVIg in autoimmune diseases -- Need for classification of the recommendations for use -- Clinical indications for IVIg therapy.
Access restricted to subscribers.
Mode of access: World Wide Web.
1529 Henry Stewart Talks
Autoimmune Diseases.
Autoimmunity.
Immunoglobulins, Intravenous--therapeutic use.
Research.